Fundraising Fox7G BioVentures — Full Portfolio
18 tracked investments · listed companies and verified rows first
Perseo Pharma is a biotech spin-off from the University of Applied Sciences in Basel, Switzerland, developing enzyme immobilization and bioconjugation technologies for therapeutic applications.
BiotechDeep TechDigital HealthMedical DevicesBasel, CH
Dr. Yves Dudal(CEO)Prof. Dr. Patrick Shahgaldian(CSO)
Aqualung Therapeutics is an early-stage therapeutics company developing a drug discovery platform and pipeline focused on advancing human health.
BiotechHealthtechMedical DevicesTucson, US
Joe G.N. Garcia(Executive Officer, Director)Joe G.N. "Skip" Garcia(Founder & Chief Executive Officer)Shawntela Martinez(Chief Financial Officer (Fractional))Augustine Choi(Chief Medical Officer (Fractional))Stan Miele(President)
Co-investorsFlorida Opportunity Fund
Clinical-stage biopharmaceutical company developing best-in-class aryl hydrocarbon receptor agonists.
BiotechEncino, US
Matthew Davidson(Executive Officer, Director)
BoardDennis Brown(Director)
Co-investorsTarnagulla Ventures
BBy manufactures a device that converts breast milk into shelf-stable powder while preserving its immunological properties, serving neonatal intensive care units seeking to reduce preparation time and milk waste.
HealthtechMedical DevicesNew York City, US
Co-investorsPioneerY CombinatorAtypical VenturesCathexis VenturesFriends Family CapitalGaingels+1 more
__Twitter.png)
BBy develops a condensed breast milk product and process that preserves bioactive immunological properties for hospital distribution.
BiotechHealthtechMedical DevicesChicago, US
BoardDr. Langer
Co-investorsBeresford VenturesOlima Ventures
Epion Therapeutics develops a minimally-invasive cross-linking treatment system called EpiSmart for keratoconus, a corneal disease, designed to preserve vision without disrupting the corneal epithelium.
BiotechDeep TechHealthtechMedical Devices
Michael D. Webb(President & CEO, Board Member)Edward Parsons(Chief Operating Officer)inMichael W. Belin(Chief Medical Officer)
Co-investorsNew World Angels
A biopharmaceutical company developing a pipeline of long-acting therapeutic candidates, including GLP-1 receptor agonists, amylin DACRAs, a PYY receptor agonist, and a glucagon receptor agonist.
BiotechSaratoga, US
Mitragotri Mitragotri(Executive Officer, Director)Ravi Srinivasan(Executive Officer, Director)in
Co-investorsCerity Partners VenturesColorcon VenturesHikma VenturesSanofi VenturesJDRF T1D Fund
A clinical-stage biotechnology company developing allogeneic CAR-T cell therapies for oncology and autoimmune diseases, targeting off-the-shelf and scalable treatments to improve patient access.
BiotechHealthtechMedical Devices
Lu Han(Chief Executive Officer)Jiangtao Ren(Chief Scientific Officer)Yajin Ni(Chief Technology Officer)
Co-investorsDecheng Capital
Kayo Therapeutics is a biotechnology company developing therapeutics, with a scientific and clinical focus that includes areas such as metabolic disease and oncology.
BiotechHealthtechSeattle, US
Mark Esposito(CSO, Co-Founder and Board Member)inYibin Kang(Chair, Scientific Advisory Board and Co-Founder)Kendall Mohler(Executive Officer, Director)Thong Q. Le(President and CEO, Board Member)Ian Howes(Chief Financial Officer)Merika Koday(COO and Board Member)in
Co-investorsBioAdvanceFoundation Venture Capital Group, LLC
Mesentech develops prostaglandin prodrugs aimed at musculoskeletal regeneration.
BiotechHealthtechVancouver
David Hyman(Executive Officer)Robert Norman Young(Executive Officer, Director)Jay Mohr(Director)David Dvorak(Director)Jonathan Polak(Executive Officer, Director, Promoter)
BoardSamuel Wu(Director)in
Co-investorsBeresford VenturesBoutique Venture PartnersWUTIF Capital
Optimeos develops a nanoparticle-based drug formulation and delivery platform (CINCs and LINCs) for complex biologics including mRNA, DNA, peptides, and proteins, targeting rare diseases, immunology, and metabolic conditions such as obesity.
BiotechDeep TechHealthtechPrinceton, US
Robert K. Prud'homme, PhD(Director)Bob Prud'homme(Leadership (PhD))Rob Pagels(Leadership (PhD))Chet Markwalter(Leadership (PhD))inShahram Hejazi(Leadership (PhD))inGregory Harriman(Leadership (MD))in
Co-investorsAnzu PartnersHatch BioFund
Persperion Diagnostics develops touch-based sweat sensing technology for diagnostic measurement.
Deep TechDigital HealthHealthtechMedical DevicesSan Diego, US
Joseph Wang(Executive Officer)Lu Yin(Executive Officer, Director)Xinyu Liu(Executive Officer)
BoardAshwin Pushpala(Director)inXuhui Shao(Director)in
Co-investorsCornucopian Capital ManagementFoothill VenturesSamsung NextEclipse Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
AqualungCurbsideCurbsidehealthEpion TherapeuticsImvivaPerseo
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.